Changing prevalence of human microsporidiosis

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 3, 2012, Pages 202-204

  Heyworth, Martin F ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

AIDS; HIV; Microsporidia; Microsporidiosis

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDLINE; MICROSPORIDIA; MICROSPORIDIOSIS; PATHOGENESIS; PREVALENCE; PUBLICATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MICROSPORIDIA; MICROSPORIDIOSIS; PREVALENCE;

MICROSPORIDIA;

EID: 84857043051     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.11.005     Document Type: Article

References (10)

1. Heyworth M.F. Giardiasis, balantidiasis, isosporiasis, and microsporidiosis. Oxford Textbook of Medicine 2010, 1111-1118. Oxford University Press, Oxford. 5th ed. D.A. Warrell, T.M. Cox, J.D. Firth (Eds.).
2. Loh R.S., Chan C.M.L., Ti S.E., Lim L., Chan K.S., Tan D.T.H. Emerging prevalence of microsporidial keratitis in Singapore: epidemiology, clinical features, and management. Ophthalmology 2009, 116:2348-2353.
3. van Hal S.J., Muthiah K., Matthews G., Harkness J., Stark D., Cooper D., et al. Declining incidence of intestinal microsporidiosis and reduction in AIDS-related mortality following introduction of HAART in Sydney, Australia. Trans R Soc Trop Med Hyg 2007, 101:1096-1100.
4. Espern A., Morio F., Miegeville M., Illa H., Abdoulaye M., Meyssonnier V., et al. Molecular study of microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon intestinalis among human immunodeficiency virus-infected patients from two geographical areas: Niamey, Niger, and Hanoi, Vietnam. J Clin Microbiol 2007, 45:2999-3002.
5. Menotti J., Santillana-Hayat M., Cassinat B., Sarfati C., Derouin F., Molina J.-M. Inhibitory activity of human immunodeficiency virus aspartyl protease inhibitors against Encephalitozoon intestinalis evaluated by cell culture-quantitative PCR assay. Antimicrob Agents Chemother 2005, 49:2362-2366.
6. Quinn T.C. HIV epidemiology and the effects of antiviral therapy on long-term consequences. AIDS 2008, 22(Suppl 3):S7-S12.
7. Santín M., Fayer R. Microsporidiosis: Enterocytozoon bieneusi in domesticated and wild animals. Res Vet Sci 2011, 90:363-371.
8. Cotte L., Rabodonirina M., Chapuis F., Bailly F., Bissuel F., Raynal C., et al. Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection. J Infect Dis 1999, 180:2003-2008.
9. Abreu-Acosta N., Lorenzo-Morales J., Leal-Guio Y., Coronado-álvarez N., Foronda P., Alcoba-Florez J., et al. Enterocytozoon bieneusi (microsporidia) in clinical samples from immunocompetent individuals in Tenerife, Canary Islands, Spain. Trans R Soc Trop Med Hyg 2005, 99:848-855.
10. Jordan M.R., Bennett D.E., Bertagnolio S., Gilks C.F., Sutherland D. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites. Antivir Ther 2008, 13(Suppl 2):15-23.